Amid the current backdrop of heightened market uncertainty, rising energy costs, stock valuations, and market volatility are weighing heavily on investors. However, there remain plenty of high-quality stocks worth considering, particularly those with competitive advantages, solid financial health, relatively low risk, and strong growth prospects. The following three stocks are considered excellent choices for investing $1,000 at the present time.
Alphabet (GOOG, GOOGL) is regarded as one of the strongest all-around stocks in the field of artificial intelligence. Whether in large language models, AI chips, autonomous driving, or robotics, the company holds a leading position across the board. Its cloud computing business, Google Cloud, has been particularly outstanding, with fourth-quarter 2025 revenue surging 48% year-over-year—the fastest growth among the three major cloud service providers—while achieving high profitability, contributing approximately 15% of Alphabet’s operating profit for the quarter.
Although its cloud business is growing rapidly, Alphabet’s primary revenue source remains its advertising business, anchored by Google Search and YouTube. Thanks to the integration of artificial intelligence, particularly the application of the Gemini model in AI Overviews and AI Mode, search traffic has further increased, driving steady and solid advertising revenue growth. From a valuation perspective, Alphabet stands out as an attractive choice among the “Magnificent Seven” tech stocks, with its share price trading at less than 23 times expected 2027 earnings, making it a typical example of a “growth at a reasonable price” investment.
Chevron (CVX) demonstrates strong investment value in the current geopolitical environment. Driven by heightened activity from Iran in the Strait of Hormuz, international oil prices have risen sharply, lifting Chevron’s stock price. As the third-largest energy company globally by market capitalization, Chevron leverages its scale and financial strength to maintain stable operations even during periods of oil price volatility.
The company’s management has set targets for double-digit growth in both adjusted free cash flow and earnings per share. Chevron holds a leading position in the natural gas market, with strong growth prospects over the coming years. Through its acquisition of Hess Corporation, Chevron is expected to significantly expand its production capacity in Guyana. Additionally, the company is the only major U.S. oil firm with a long-standing operational presence in Venezuela, giving it a unique geographical advantage.
In terms of dividends, Chevron has increased its payout for 39 consecutive years, with a current dividend yield exceeding 3.5%. Even in an extreme scenario where oil prices fall below $50 per barrel, the company would still be able to cover its dividend payments and all capital expenditures, highlighting its strong financial resilience.
In the pharmaceutical sector, Eli Lilly (LLY) is seen as a defensive investment. In recent years, the company has achieved rapid growth driven by its two GLP-1 drugs—Mounjaro for type 2 diabetes and Zepbound for obesity—which together generated $36.5 billion in sales last year, with further growth potential still ahead.
Beyond diabetes and obesity, Eli Lilly’s business portfolio is relatively diversified. Its breast cancer drug Verzenio has become a blockbuster product, and the company holds significant positions in therapeutic areas such as autoimmune diseases and Alzheimer’s disease. Although there are some concerns about its valuation, the company’s growth potential is sufficient to support its relatively high valuation. Currently, Eli Lilly’s share price trades at nearly 27 times expected 2026 earnings, while its forward price-to-earnings ratio based on 2030 earnings projections stands at approximately 15 times.
